A panel that issues advice on U.S. vaccine policy appears prepared to vote Thursday to recommend a delay in when most babies ...

The FDA plans to reduce its default requirement to one clinical study, instead of the standard two, for medical products ...

A top Senate health leader called a federal panel of vaccine advisers “totally discredited” just minutes ahead of its planned ...

In today's D.C. Diagnosis newsletter: more big personnel changes plus new clinical trial standards at the FDA.

In other news, ASH is upon us! If you’re going to be in Orlando, don’t forget to drop by STAT’s event tomorrow evening.

Paradigm Health, which is seeking to use AI to enroll clinical trials, has raised more funds and is acquiring a business from ...

The FDA plans to begin requiring one clinical study, instead of the standard two, for medical products before consideration ...

Trump’s reshaping of science has fueled fears researchers will leave the U.S. This lab tech's story shows it can drive people ...

West Virginia wasn’t the only state with anti-tobacco initiatives that suffered after OSH closed down. New York state’s ...

Trump has "shaken the hell" out of the 80-year research pact between the government and universities. What now?

Science and data are important, research shows, but people are incredibly receptive to personal stories about public health.

STAT's Alex Hogan has what you to know about subclade K, the new flu variant, on this week's episode of STATus Report.